These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27578036)

  • 41. Complete pathologic response in soft tissue sarcoma lung metastases with pazopanib.
    Eroglu Z; Kim J; Wilczynski S; Chow WA
    J Thorac Oncol; 2014 Jan; 9(1):e4-6. PubMed ID: 24346105
    [No Abstract]   [Full Text] [Related]  

  • 42. Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels.
    Groenland SL; Katz D; Huitema ADR; Steeghs N
    BMC Cancer; 2018 Dec; 18(1):1200. PubMed ID: 30509247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pazopanib in the treatment of soft tissue sarcoma.
    Schöffski P
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):711-23. PubMed ID: 22716487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib.
    Mori Y; Kinoshita S; Kanamori T; Kataoka H; Joh T; Iida S; Takemoto M; Kondo M; Kuroda J; Komatsu H
    Intern Med; 2018 Sep; 57(18):2753-2757. PubMed ID: 29780156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Myxoid leiomyosarcoma of the uterus.
    Kunzel KE; Mills NZ; Muderspach LI; d'Ablaing G
    Gynecol Oncol; 1993 Feb; 48(2):277-80. PubMed ID: 8428703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discordant responses to progestin in a patient with uterine low-grade smooth-muscle tumors metastatic to the lung.
    Lo CA; Huang SC; Ho CL; Tzeng CC; Chou CY; Hsu KF
    J Obstet Gynaecol Res; 2005 Oct; 31(5):394-8. PubMed ID: 16176506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Promising effects of pazopanib with radiation on an advanced prostate leiomyosarcoma after failure of systemic chemotherapy.
    Lin MH; Hsiao HH
    Kaohsiung J Med Sci; 2019 May; 35(5):317-318. PubMed ID: 30887661
    [No Abstract]   [Full Text] [Related]  

  • 48. Pazopanib-mediated long-term disease stabilization after resection of a uterine leiomyosarcoma metastasis to the brain: A case report.
    Inoue K; Tsubamoto H; Tomogane Y; Kamihigashi M; Shibahara H
    Gynecol Oncol Rep; 2016 Aug; 17():60-4. PubMed ID: 27617285
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-dose tamoxifen modulates drug resistance to doxorubicin, dacarbazine and ifosfamide in metastatic uterine leiomyosarcoma.
    Yeh KH; Lu YS; Hsiao CH; Cheng AL
    Anticancer Res; 2003; 23(6D):5133-7. PubMed ID: 14986591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incorporation of pazopanib in maintenance therapy of ovarian cancer.
    du Bois A; Floquet A; Kim JW; Rau J; del Campo JM; Friedlander M; Pignata S; Fujiwara K; Vergote I; Colombo N; Mirza MR; Monk BJ; Kimmig R; Ray-Coquard I; Zang R; Diaz-Padilla I; Baumann KH; Mouret-Reynier MA; Kim JH; Kurzeder C; Lesoin A; Vasey P; Marth C; Canzler U; Scambia G; Shimada M; Calvert P; Pujade-Lauraine E; Kim BG; Herzog TJ; Mitrica I; Schade-Brittinger C; Wang Q; Crescenzo R; Harter P
    J Clin Oncol; 2014 Oct; 32(30):3374-82. PubMed ID: 25225436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pulmonary metastasis fifteen years after hysterectomy for uterine leiomyosarcoma; report of a case].
    Kato H; Kanauchi N
    Kyobu Geka; 2011 Sep; 64(10):941-3. PubMed ID: 21899134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pazopanib for the treatment of metastatic renal cell carcinoma.
    Pick AM; Nystrom KK
    Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of bilateral spontaneous pneumothorax during pazopanib therapy for pulmonary soft tissue sarcoma metastases. What to do when there is so few evidence?].
    Agrafiotis AC; Prieto M; Verhaeghe JL; Siat J; Grosdidier G; Rios M
    Rev Pneumol Clin; 2016 Oct; 72(5):293-295. PubMed ID: 27561973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of advanced uterine leiomyosarcoma.
    Hyman DM; Grisham RN; Hensley ML
    Curr Opin Oncol; 2014 Jul; 26(4):422-7. PubMed ID: 24840518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pazopanib does not bring remarkable improvement in patients with angiosarcoma.
    Kitamura S; Yanagi T; Inamura Y; Hata H; Imafuku K; Yoshino K; Shimizu H
    J Dermatol; 2017 Jan; 44(1):64-67. PubMed ID: 27569550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical status and prognostic factors in Japanese patients with uterine leiomyosarcoma.
    Takehara K; Yamashita N; Watanabe R; Teramoto N; Tsuda H; Motohashi T; Harano K; Nakanishi T; Tokunaga H; Susumu N; Ueda Y; Yokoyama Y; Saito T
    Gynecol Oncol; 2020 Apr; 157(1):115-120. PubMed ID: 31983515
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaginal metastasis as the initial presentation of leiomyosarcoma: a case report.
    Villalaín-González C; Tejerizo-García Á; Lopez-Garcia P; López-González G; Oliver-Perez MR; Jiménez-López JS
    BMC Cancer; 2017 Jul; 17(1):503. PubMed ID: 28747229
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials.
    Duffaud F; Sleijfer S; Litière S; Ray-Coquard I; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla SP; Dewji R; Marreaud S; Verweij J; van der Graaf WT
    Eur J Cancer; 2015 Nov; 51(17):2615-23. PubMed ID: 26321011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.
    Monk BJ; Mas Lopez L; Zarba JJ; Oaknin A; Tarpin C; Termrungruanglert W; Alber JA; Ding J; Stutts MW; Pandite LN
    J Clin Oncol; 2010 Aug; 28(22):3562-9. PubMed ID: 20606083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uterine sarcoma with posterior reversible encephalopathy syndrome associated with pazopanib.
    Tatsumichi T; Tanaka H; Okazaki T; Takahashi K; Suzuki K; Kawakita K; Houchi H; Kuroda Y; Kosaka S
    J Clin Pharm Ther; 2021 Feb; 46(1):223-226. PubMed ID: 33044009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.